HCPLive Network

CDC Addresses Burden, Threat of Antibiotic Resistance

MONDAY, Jan. 6, 2014 (HealthDay News) -- The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Noting that antibiotic resistance is a worldwide problem, researchers from the CDC discuss the burden and threat of antibiotic resistance to bacteria that can cause severe human infections.

The researchers note that antibiotic resistance causes an estimated minimum of two million illnesses and 23,000 deaths per year, and one of the most urgent threats is Clostridium difficile, which causes an estimated minimum of 250,000 illnesses and 14,000 deaths per year. The estimated costs of antibiotic resistance could be as high as $20 billion in direct costs and $35 billion in indirect costs such as lost productivity. Antibiotic use is the most important factor leading to antibiotic resistance, with up to 50 percent of antibiotics prescribed inappropriately. The spread of resistant strains from person to person or from non-human sources is also a major factor in antibiotic resistance. The four core actions to combat antibiotic-resistant infection are prevention of infections and of the spread of resistance; tracing resistant bacteria; improving antibiotic use; and promoting the development of new antibiotics.

"When first-line and then second-line antibiotic treatment options are limited by resistance or are unavailable, health care providers are forced to use antibiotics that may be more toxic to the patient and frequently more expensive and less effective," CDC Director Tom Frieden, M.D., M.P.H., said in a statement.

More Information


Copyright © 2014 HealthDay. All rights reserved.

Further Reading
Although patients are expressing more of an interest in accessing their health information online, just a third of patients have access to patient portals, and the rest either don't have access or are not sure if they do.
As more pediatric surgical procedures being conducted as same-day procedures, parents are assuming responsibility for their children’s immediate post-operative pain management.
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
There is a significantly increased risk of cardiac death associated with clarithromycin use, according to a study published online Aug. 19 in BMJ.
As the 2 Americans stricken with Ebola continue to receive treatment in Atlanta, a new potential case of the deadly virus has been reported in California.
Active surveillance for clinical stage I testis cancer leads to excellent outcomes, according to a study published online Aug. 18 in the Journal of Clinical Oncology.
Pistachio consumption is associated with improvements in glucose and cardiometabolic parameters, according to a study published online Aug. 14 in Diabetes Care.
More Reading